ArticleInvestigative ophthalmology & visual science2025
Ubap1l Knockout Mice Model Recapitulates Retinal Degeneration Phenotype Observed in Patients and Exhibits Irregular Photoreceptor Morphology.
Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: UBAP1L is a newly discovered gene related to recessive inherited retinal degeneration (IRD) with an unknown pathogenic mechanism. This study aims to investigate whether biallelic pathogenic variants in UBAP1L contribute to the unsolved cases in Chinese IRD families and to explore the impact of the Ubap1l genetic defect in a mouse model. Methods: Next-generation sequencing was used to detect variants in families with unknown pathogenic variants. Biallelic variants in UBAP1L, evaluated through multistep bioinformatic analysis, comparison across multiple databases, and related phenotype analysis based on thoroughly reviewed clinical data, were confirmed by Sanger sequencing and cosegregation analysis. The expression profiles of UBAP1L in human and Ubap1l in mouse were demonstrated using quantitative RT-PCR and RNAscope. Phenotype and photoreceptor morphology were analyzed in the Ubap1l knockout mouse model. Results: Biallelic novel pathogenic variants in UBAP1L were exclusively detected in two unrelated families with retinitis pigmentosa (RP), including a homozygous c.[278C>A;280dup]/p.[(T93K;I94fs)] variant in one family and compound heterozygous variants (i.e., c.[278C>A;280dup]/p.[(T93K;I94fs)] and c.1051A>G/p.M351V) in the other family. Quantitative RT-PCR showed that UBAP1L was highly expressed in human and mouse retina. RNAscope analysis revealed that UBAP1L was specifically expressed in the outer nuclear and inner segments in the human and mouse retina. Notably, in the human retina, UBAP1L was more highly expressed in cones, with low but detectable expression in the RPE, whereas this expression pattern was not observed in the mouse retina. Ubap1l knockout mice exhibited mottled retinal degeneration, impaired photoreceptor function, and deformation of the rod outer segments. Conclusions: For the first time, biallelic pathogenic variants in UBAP1L were reported to explain the genetic defect among East Asian families with RP. The expression profile and precise localization of UBAP1L were demonstrated. A Ubap1l knockout mouse model replicating key hallmarks of IRD was established. These findings provide valuable insights into the essential role of UBAP1L in maintaining photoreceptor function and offer potential avenues for therapeutic development targeting IRD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.